Prognostic Value of Residual Node Involvement in Operable Breast Cancer after Induction Chemotherapy

被引：0
|
作者：
Hervé Curé
Sophie Amat
Frédérique Penault-Llorca
Guillaume le Bouëdec
Jean-Pierre Ferrière
Marie-Ange Mouret-Reynier
Fabrice Kwiatkowski
Viviane Feillel
Jacques Dauplat
Philippe Chollet
机构：
[1] Centre Jean Perrin,
[2] INSERM U484,undefined
来源：
Breast Cancer Research and Treatment | 2002年 / 76卷
关键词：
breast cancer; long-term effect; neoadjuvant chemotherapy; node involvement; prognostic factor;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
The purpose of this retrospective study was to evaluate the influence of axillary disease on patients' survival after neoadjuvant chemotherapy and to assess patient and tumor characteristics associated with post-chemotherapy axillary involvement.
引用
收藏
页码：37 / 45
页数：8
相关论文
共 50 条
  • [41] Node Micrometastases Detection After Neoadjuvant Chemotherapy in Breast Cancer: Is It of Clinical Value?
    Dimosthenis Ziogas
    Haralampos Harissis
    Charalabos Batsis
    Annals of Surgical Oncology, 2010, 17 : 933 - 934
  • [42] Dedicated breast PET for detecting residual disease after neoadjuvant chemotherapy in operable breast cancer: A prospective cohort study
    Sasada, Shinsuke
    Masumoto, Norio
    Goda, Noriko
    Kajitani, Keiko
    Emi, Akiko
    Kadoya, Takayuki
    Okada, Morihito
    EJSO, 2018, 44 (04): : 444 - 448
  • [43] Clinicopathologic factors related to margin involvement, reoperation, and residual breast cancer in primary operable breast cancer
    Lai, H. -W.
    Chen, S. -T.
    Chen, D. -R.
    ANNALS OF ONCOLOGY, 2015, 26 : 24 - 24
  • [44] Prognostic significance of residual nodal burden using lymph node ratio in locally advanced breast cancer after neoadjuvant chemotherapy
    Agarwal, Reshu
    Philip, Arun
    Pavithran, Keechilat
    Rajanbabu, Anupama
    Goel, Gaurav
    Vijaykumar, D. K.
    INDIAN JOURNAL OF CANCER, 2019, 56 (03) : 228 - 235
  • [45] Prognostic value of hormone receptor status conversion following neoadjuvant chemotherapy in a series of operable breast cancer patients
    Tan, Qi-Xing
    Qin, Qing-Hong
    Yang, Wei-Ping
    Lian, Bin
    Wei, Chang-Yuan
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2014, 7 (07): : 4086 - 4094
  • [46] Changes in and prognostic value of hormone receptor status in a series of operable breast cancer patients treated with neoadjuvant chemotherapy
    Tacca, Olivier
    Penault-Llorca, Frederique
    Abrial, Catherine
    Mouret-Reynier, Marie-Ange
    Raoelfils, Ines
    Durando, Xavier
    Achard, Jean-Louis
    Gimbergues, Pierre
    Cure, Herve
    Chollet, Phillipe
    ONCOLOGIST, 2007, 12 (06): : 636 - 643
  • [47] The residual cancer burden index as a valid prognostic indicator in breast cancer after neoadjuvant chemotherapy
    Xu, Xin
    Zhao, Wei
    Liu, Cuicui
    Gao, Yongsheng
    Chen, Dawei
    Wu, Meng
    Li, Chao
    Wang, Xinzhao
    Song, Xiang
    Yu, Jinming
    Liu, Zhaoyun
    Yu, Zhiyong
    BMC CANCER, 2024, 24 (01)
  • [48] Neoadjuvant Chemotherapy (NCT) in 466 Patients for Operable Breast Cancer: The Prognostic Value of SBR Grade Variation.
    Abrial, C.
    Mouret-Reynier, M-A
    Wang-Lopez, Q.
    Durando, X.
    Thivat, E.
    Raoelfils, I.
    Gimbergues, P.
    Van Praagh-Doreau, I
    Nabholtz, J-M
    Chollet, P.
    Penault-Llorca, F.
    CANCER RESEARCH, 2011, 71
  • [49] Prognostic factors for and pattern of lymph-node involvement in patients with operable cervical cancer
    Widschwendter, P.
    Janni, W.
    Scholz, C.
    De Gregorio, A.
    De Gregorio, N.
    Friedl, T. W. P.
    ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2019, 300 (06) : 1709 - 1718
  • [50] Prognostic factors for and pattern of lymph-node involvement in patients with operable cervical cancer
    P. Widschwendter
    W. Janni
    C. Scholz
    A. De Gregorio
    N. De Gregorio
    T W P Friedl
    Archives of Gynecology and Obstetrics, 2019, 300 : 1709 - 1718
12345